Nature Cancer
Nature Cancer aims to publish the most significant advances across the full spectrum of cancer research in the life, physical, applied and social sciences, …
Related Articles
Associate or Senior Editor, Nature Cancer – Shanghai, Beijing, New York or Philadelphia – Hybrid working model
About Springer Nature Group Springer Nature opens the doors to discovery for researchers, educators, clinicians and other professionals. Every day,…
Locum Associate or Senior Editor, Nature Cancer – Berlin, Heidelberg or London – Hybrid working model
The Associate or Senior Editor will contribute to shaping the future of Nature Cancer journal.
Associations of seven measures of biological age acceleration with frailty and all-cause mortality among adult survivors of childhood cancer in the St. Jude Lifetime Cohort
Nature Cancer – Guida et al. assess seven measures of biological age in SJLIFE Cohort and reveal that survivors of cancer age faster than healthy…
Associate or Senior Editor, Nature Cancer – Shanghai, Beijing, New York or Philadelphia – Hybrid working model
About Springer Nature Group Springer Nature opens the doors to discovery for researchers, educators, clinicians and other professionals. Every day,…
The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors – Nature Cancer
Benoit and colleagues identify the dopamine transporter antagonist vanoxerine as a suppressor of G9a methyltransferase and show that treatment leads to cancer stem cell suppression…
Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance
Nature Cancer – Zheng et al. generate and utilize a biobank of colorectal cancer PDOs to find that high LGR4 is linked to chemoresistance. They…
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2
Nature Cancer – Chaib et al. find that therapy-induced senescent cells have high programmed cell death 1 ligand 2 (PD-L2), contributing to recurrence. They show…
Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance
Nature Cancer – Zheng et al. generate and utilize a biobank of colorectal cancer PDOs to find that high LGR4 is linked to chemoresistance. They…
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma
Nature Cancer – Gammage and colleagues find that mitochondrial DNA mutations induce alterations in redox metabolism, a remodeled tumor microenvironment characterized by a loss of…
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2
Nature Cancer – Chaib et al. find that therapy-induced senescent cells have high programmed cell death 1 ligand 2 (PD-L2), contributing to recurrence. They show…